Issuu on Google+

Consolidated Investment Analysis For Johnson & Johnson Johnson & Johnson (NYSE: JNJ) Company Description Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. In July 2009, Johnson & Johnson completed the acquisition of Cougar Biotechnology, Inc. with approximately 95.9% interest in Cougar Biotechnology's outstanding common stock. In September 2009, Elan Corporation, plc and Johnson & Johnson announced that JANSSEN Alzheimer Immunotherapy, a newly formed subsidiary of Johnson & Johnson, has completed the acquisition of substantially all of the assets and rights of Elan related to its Alzheimer`s Immunotherapy Program (AIP). In March 2010, Hypermarcas SA acquired 99.99% of Versoix Participacoes Ltda from the Company. Share Statistics Symbol Current Price 52wk Range Avg Vol (3m)

JNJ 59.22 55.71- 66.20 14,734,500

EPS Market Cap 52wk Change P/E (ttm)

4.76 163.33B 4.65% 12.44

Financial Summary On April 20, 2010, Johnson & Johnson reported 1st quarter 2010 earnings of 1.29 per share. This result was in line with the consensus of the 16 analysts following the company and exceeded last year's 1st quarter results by 2.38%. The next earnings announcement is expected on July 20, 2010. Johnson & Johnson reported annual 2009 earnings of 4.63 per share on January 26, 2010. The next earnings announcement from Johnson & Johnson is expected the week of January 25, 2011. JNJ had 1st quarter 2010 revenues of 15.63bn. This bettered the 15.60bn consensus of the 15 analysts covering the company. This was -5.56% below the prior year's 1st quarter results. JNJ had revenues for the full year 2009 of 61.90bn. This was -2.90% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 22 polled investment analysts. Against the Johnson & Johnson company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

11

4

7

0

0

0

4 weeks ago

11

4

7

0

0

0

2 months ago

11

4

7

0

0

0

3 months ago

11

4

7

0

0

0

Last year

8

3

7

0

0

0

The 17 analysts offering 12 month price targets for Johnson & Johnson (JNJ:NYQ) have a median target of 69.00, with a high estimate of 90.00 and a low estimate of 60.00. The median estimate represents a 16.06% increase from the last price of 59.45.

# of Estimates

Mean

High

1 Year Ago

Low

SALES (in millions)

Quarter Ending Jun-10

14

15,827.60

16,259.00

15,587.00

15,573.00

Quarter Ending Sep-10

14

15,565.80

15,957.00

15,152.00

15,742.00

Year Ending Dec-10

18

63,623.60

64,508.00

62,226.70

63,227.70

Year Ending Dec-11

16

66,679.80

68,002.00

64,798.70

66,269.50

Quarter Ending Jun-10

16

1.22

1.28

1.16

1.20

Quarter Ending Sep-10

14

1.20

1.26

1.13

1.24

Year Ending Dec-10

20

4.81

4.91

4.68

4.87

Year Ending Dec-11

18

5.21

5.42

5.01

5.36

LT Growth Rate (%)

8

7.18

9.00

6.00

8.18

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans 2,000

2

206,842

4

(204,842)

6

937.74K

N/A

(17.8%)

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(12,261,200) (0.7%)


DIRECT COMPETITOR COMPARISON

JNJ

ABT

LLY

NVS

Industry

Market Cap:

162.97B

72.05B

37.18B

110.19B

87.53M

Employ ees:

115,500

73,000

40,360

100,000

142.00

4.00%

14.60%

8.70%

24.50%

15.30%

Revenue (ttm):

62.50B

31.74B

22.27B

47.50B

34.95M

Gross Margin (ttm):

70.22%

57.13%

79.56%

72.98%

73.29%

EBITDA (ttm):

19.73B

9.21B

7.62B

13.78B

-1.64M

Oper Margins (ttm):

27.03%

22.11%

28.40%

23.89%

20.60%

Net Income (ttm):

13.28B

5.31B

4.26B

9.37B

N/A

EPS (ttm):

4.76

3.412

3.877

4.113

N/A

P/E (ttm):

12.41

13.68

8.69

11.71

10.43

PEG (5 yr expected):

1.72

1.15

N/A

2.19

1.72

P/S (ttm):

2.62

2.29

1.69

2.36

3.09

Qtrly Rev Growth (yoy):


Consolidated Investment Analysis for AK Steel Holding Corp AK Steel Holding Corp. (NYSE: AKS) Company Description AK Steel Holding Corporation (AK Holding) is a producer of flat-rolled carbon, stainless and electrical steels, and tubular products through its wholly owned subsidiary, AK Steel Corporation (AK Steel). The Company's operations consist of seven steelmaking and finishing plants located in Indiana, Kentucky, Ohio and Pennsylvania that produce flat-rolled carbon steels, including coated, cold-rolled and hotrolled products, and specialty stainless and electrical steels that are sold in hot band, and sheet and strip form. The Company's operations also include AK Tube LLC (AK Tube), which finishes flat-rolled carbon and stainless steel at two tube plants, one located in Ohio and one located in Indiana, into welded steel tubing used in the automotive, large truck and construction markets. In addition, the Company's operations include European trading companies that buy and sell steel and steel products and other materials. Share Statistics

Symbol Current Price 52wk Range Avg Vol (3m)

AKS 12.20 12.16- 26.75 12,135,900

EPS Market Cap 52wk Change P/E (ttm)

0.01 1.34B -37.41% 1,219.93

Financial Summary On April 20, 2010, AK Steel Holding Corp reported 1st quarter 2010 earnings of 0.02 per share. This result under-performed the 0.25 consensus expectations of the 12 analysts following the company but under-performed last year's 1st quarter results by 0.69. The next earnings announcement is expected on July 19, 2010. AK Steel Holding Corp reported annual 2009 losses of -0.64 per share on January 25, 2010. AKS had 1st quarter 2010 revenues of 1.41bn. This bettered the 1.40bn consensus of the 8 analysts covering the company. This was 6.50% above the prior year's 1st quarter results. AKS had revenues for the full year 2009 of 4.08bn. This was -46.67% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 12 polled investment analysts. Against the AK Steel Holding Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

1

1

10

0

0

0

4 weeks ago

1

1

10

0

0

0

2 months ago

0

1

10

1

0

0

3 months ago

1

2

7

1

0

0

Last year

1

2

6

2

1

0

The 8 analysts offering 12 month price targets for AK Steel Holding Corp (AKS:NYQ) have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a 42.64% increase from the last price of 13.32.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

6

1,521.94

1,574.70

1,380.00

1,170.50

Quarter Ending Sep-10

5

1,503.68

1,629.00

1,345.50

1,181.50

Year Ending Dec-10

9

5,968.34

6,311.00

5,318.40

5,022.54

Year Ending Dec-11

9

6,491.51

6,869.18

5,975.00

5,709.29

Quarter Ending Jun-10

11

0.11

0.30

-0.33

0.15

Quarter Ending Sep-10

9

0.27

0.38

0.11

0.24

Year Ending Dec-10

12

0.86

1.10

0.56

0.96

Year Ending Dec-11

12

1.78

2.45

1.25

2.04

LT Growth Rate (%)

1

10.00

10.00

10.00

-6.00

Earnings (per share)

Technical Analysis Chart


NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans N/A

0

261,883

6

(261,883)

6

1.1M

N/A

(19.2%)

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(33,293,600) (63.2%)


DIRECT COMPETITOR COMPARISON

AKS

Pvt1

NUE

STLD

Industry

Market Cap:

1.35B

N/A

12.24B

2.90B

1.25B

Employ ees:

6,500

20,5001

20,400

5,990

4.38K

52.40%

N/A

37.70%

91.00%

15.60%

4.56B

12.90B1

12.19B

4.70B

1.98B

10.75%

N/A

4.03%

13.83%

12.59%

305.70M

N/A

712.19M

586.17M

105.35M

Oper Margins (ttm):

1.92%

N/A

1.13%

7.78%

5.07%

Net Income (ttm):

1.10M

N/A

-75.09M

144.65M

N/A

0.01

N/A

-0.238

0.687

0.26

1224.00

N/A

N/A

19.49

20.50

PEG (5 yr expected):

1.57

N/A

1.83

1.16

1.09

P/S (ttm):

0.32

N/A

1.04

0.64

0.97

Qtrly Rev Growth (yoy): Revenue (ttm): Gross Margin (ttm): EBITDA (ttm):

EPS (ttm): P/E (ttm):


Consolidated Investment Analysis for General Electric Co. General Electric Co. (NYSE: GE)

Company Description General Electric Company (GE) is a diversified technology, media and financial services company. The Company's products and services include aircraft engines, power generation, water processing, security technology, medical imaging, business and consumer financing, media content and industrial products. The Company serves customers in more than 100 countries. The Company operates through five segments: Energy Infrastructure, Technology Infrastructure, NBC Universal (NBCU), Capital Finance and Consumer & Industrial. In March 2009, Teleflex Incorporated completed the sale of its 51% share of Airfoil Technologies International - Singapore Pte. Ltd., to GE. In September 2009, the Company sold its 81% interest in Homeland Protection business to Safran SA. In September 2009, the Company acquired ScanWind. In September 2009, Moog Inc. completed the acquisition of the Company's GE Aviation Systems' flight control actuation business. In November 2009, GE Aviation acquired Naverus, Inc. Share Statistics Symbol Current Price 52wk Range Avg Vol (3m)

GE 14.52 10.50-19.70 85,017,900

EPS Market Cap 52wk Change P/E (ttm)

0.92 155.02B 23.50% 15.75

Financial Summary On April 16, 2010, General Electric Co reported 1st quarter 2010 earnings of 0.21 per share. This result exceeded the 0.16 consensus of the 11 analysts covering the company and under-performed last year's 1st quarter results by -19.23%. The next earnings announcement is expected on July 16, 2010. General Electric Co reported annual 2009 earnings of 1.03 per share on January 22, 2010. GE had 1st quarter 2010 revenues of 36.60bn. This missed the 37.28bn consensus estimate of the 8 analysts following the company. This was -11.66% below the prior year's 1st quarter results. GE had revenues for the full year 2009 of 156.78bn. This was -14.10% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 14 polled investment analysts. Against the General Electric Co company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

2

6

6

0

0

0

4 weeks ago

2

6

6

0

0

0

2 months ago

2

5

6

0

0

0

3 months ago

2

5

6

0

0

0

Last year

1

3

10

0

1

1

The 12 analysts offering 12 month price targets for General Electric Co (GE:NYQ) have a median target of 21.50, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a 43.33% increase from the last price of 15.00.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

8

38,599.30

39,831.00

36,985.00

39,715.10

Quarter Ending Sep-10

8

38,694.00

40,358.00

37,968.00

40,023.60

Year Ending Dec-10

11

155,856.00

161,456.00

150,000.00

160,884.00

Year Ending Dec-11

10

153,348.00

164,505.00

143,823.00

165,815.00

Quarter Ending Jun-10

12

0.27

0.28

0.24

0.19

Quarter Ending Sep-10

10

0.27

0.28

0.26

0.20

Year Ending Dec-10

14

1.09

1.14

1.00

0.93

Year Ending Dec-11

13

1.32

1.49

1.19

1.20

LT Growth Rate (%)

6

11.62

16.00

5.00

8.92

Earnings (per share)


Technical Analysis

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases

Trans N/A

0

4,890

1

(4,890)

1

Total Insider Shares Held

2.67M

N/A

% Net Shares Purchased (Sold)

(0.2%)

N/A

Sales Net Shares Purchased (Sold)

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

42,147,200 0.8%


DIRECT COMPETITOR COMPARISON

GE

C

Market Cap:

155.08B

109.83B

27.95B

78.16B

5.28B

Employ ees:

304,000

263,000

116,186

402,000

32.00K

-4.80%

16.80%

11.90%

-3.80%

14.90%

154.95B

43.97B

29.44B

91.14B

10.18B

Gross Margin (ttm):

31.59%

N/A

37.15%

28.07%

33.86%

EBITDA (ttm):

16.93B

N/A

3.58B

11.21B

811.00M

7.54%

-11.70%

6.98%

8.59%

10.05%

10.40B

-3.76B

827.99M

3.78B

N/A

EPS (ttm):

0.922

-0.224

0.889

4.358

0.92

P/E (ttm):

15.75

N/A

33.85

20.65

16.17

PEG (5 yr expected):

1.17

N/A

0.88

0.38

1.22

P/S (ttm):

1.03

2.64

0.99

0.89

1.20

Qtrly Rev Growth (yoy): Revenue (ttm):

Oper Margins (ttm): Net Income (ttm):

PHG

SI

Industry


Consolidated Investment Analysis for Pfizer Inc. Pfizer Inc. (NYSE: PFE) Company Description Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizer's diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer health care products. The Company operates in two business segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, and Consumer Healthcare products. On October 15, 2009, the Company completed its acquisition of Wyeth. In December 2009, Durata Therapeutics, Inc. acquired Vicuron Pharmaceuticals from Pfizer. Share Statistics

Symbol Current Price 52wk Range Avg Vol (3m)

PFE 16.90 12.75- 20.36 60,004,800

EPS Market Cap 52wk Change P/E (ttm)

1.23 136.39B 20.80% 13.78

Financial Summary On February 03, 2010, Pfizer Inc reported 4th quarter 2009 earnings of 0.49 per share. This result was in line with the consensus of the 14 analysts following the company and under-performed last year's 4th quarter results by -23.44%. The next earnings announcement is expected on May 04, 2010. Pfizer Inc reported annual 2009 earnings of 2.02 per share on February 03, 2010. PFE had 4th quarter 2009 revenues of 16.54bn. This bettered the 15.90bn consensus of the 12 analysts covering the company. This was 42.52% above the prior year's 4th quarter results. PFE had revenues for the full year 2009 of 50.01k. This was 3.45% above the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 20 polled investment analysts. Against the Pfizer Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

8

6

5

0

1

0

4 weeks ago

8

6

6

0

1

0

2 months ago

8

6

6

0

1

0

3 months ago

9

6

6

0

0

0

Last year

7

3

7

0

0

2

The 16 analysts offering 12 month price targets for Pfizer Inc (PFE:NYQ) have a median target of 21.50, with a high estimate of 30.00 and a low estimate of 17.00. The median estimate represents a 25.88% increase from the last price of 17.08.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

11

16,939.50

17,500.00

16,430.00

11,435.00

Quarter Ending Sep-10

11

17,095.90

17,565.00

16,435.00

11,720.00

Year Ending Dec-10

16

67,167.70

69,565.00

50,083.00

55,530.00

Year Ending Dec-11

14

67,207.10

68,598.00

63,400.00

57,313.90

Quarter Ending Jun-10

12

0.54

0.58

0.51

0.46

Quarter Ending Sep-10

12

0.57

0.60

0.55

0.54

Year Ending Dec-10

19

2.18

2.30

2.07

2.29

Year Ending Dec-11

18

2.30

2.42

2.10

2.38

LT Growth Rate (%)

5

1.67

3.00

-1.00

-1.21

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares

Trans

Purchases

N/A

0

Sales

N/A

0

N/A

0

3.79M

N/A

0.0%

N/A

Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold) Net Institutional Purchases - Prior Qtr to Latest Qtr

Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

781,177,000 12.0%


DIRECT COMPETITOR COMPARISON

PFE

BAYRY.PK

MRK

NVS

Industry

Market Cap:

136.39B

N/A

116.48B

121.75B

138.91M

Employ ees:

116,500

N/A

100,000

99,834

221

N/A

N/A

67.30%

27.40%

14.60%

Revenue (ttm):

50.01B

N/A

27.43B

45.08B

31.21M

Gross Margin (ttm):

83.92%

N/A

67.54%

72.87%

72.87%

EBITDA (ttm):

21.27B

N/A

7.08B

12.54B

-1.59M

Oper Margins (ttm):

33.02%

N/A

17.70%

22.80%

12.81%

Net Income (ttm):

8.62B

N/A

12.85B

8.40B

N/A

EPS (ttm):

1.226

N/A

5.654

3.69

N/A

P/E (ttm):

13.78

N/A

6.61

14.51

14.33

PEG (5 yr expected):

4.88

2.14

3.36

1.81

1.81

P/S (ttm):

2.76

N/A

4.28

2.72

3.10

Qtrly Rev Growth (yoy):


Consolidated Investment Analysis For United States Steel Corp. United States Steel Corp. (NYSE: X) Company Description United States Steel Corporation (U. S. Steel) is an integrated steel producer of flat-rolled and tubular products with production operations in North America and Europe. The Company has an annual raw steel production capability of 31.7 million net tons (tons) (24.3 million tons in North America and 7.4 million tons in Europe). U. S. Steel is also engaged in other business activities, which are related to steelmaking operations, including the production of coke and iron ore pellets, and transportation services (railroad and barge operations), real estate operations, and engineering consulting services. It operates in three segments: Flat-rolled Products (Flat-rolled), U. S. Steel Europe (USSE) and Tubular Products (Tubular). On January 31, 2009, the Company completed the sale of a majority of the operating assets of Elgin, Joliet and Eastern Railway Company (EJ&E) to a subsidiary of Canadian National Railway Company. Share Statistics Symbol Current Price 52wk Range Avg Vol (3m)

X 39.11 29.35- 70.95 17,237,700

EPS Market Cap 52wk Change P/E (ttm)

-7.92 5.61B 5.96% N/A

Financial Summary On April 27, 2010, United States Steel Corp reported 1st quarter 2010 losses of -1.12 per share. This result exceeded the -1.39 consensus loss of the 12 analysts covering the company and under-performed last year's 1st quarter results by -70.83%. The next earnings announcement is expected on July 26, 2010. United States Steel Corp reported annual 2009 losses of -11.06 per share on January 26, 2010. X had 1st quarter 2010 revenues of 3.90bn. This bettered the 3.83bn consensus of the 5 analysts covering the company. This was 16.16% above the prior year's 1st quarter results. X had revenues for the full year 2009 of 11.05bn. This was -53.61% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 13 polled investment analysts. Against the United States Steel Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

4

5

3

0

1

0

4 weeks ago

4

5

2

0

2

0

2 months ago

4

5

2

0

2

0

3 months ago

4

4

3

0

2

0

Last year

1

2

7

1

2

0

The 12 analysts offering 12 month price targets for United States Steel Corp (X:NYQ) have a median target of 62.00, with a high estimate of 86.00 and a low estimate of 46.00. The median estimate represents a 49.22% increase from the last price of 41.55.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

5

4,654.61

4,944.34

4,386.00

3,393.00

Quarter Ending Sep-10

4

4,886.24

5,052.00

4,728.00

3,357.50

Year Ending Dec-10

8

18,015.10

18,586.00

17,304.00

14,991.80

Year Ending Dec-11

8

20,693.10

22,298.80

19,412.00

16,376.80

Quarter Ending Jun-10

12

0.59

0.83

0.35

0.68

Quarter Ending Sep-10

8

1.29

1.78

0.96

0.57

Year Ending Dec-10

13

1.89

3.65

0.85

1.41

Year Ending Dec-11

13

5.76

10.00

3.00

3.50

LT Growth Rate (%)

2

17.50

30.00

5.00

4.00

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans N/A

0

18,770

1

(18,770)

1

433.02K

N/A

(4.2%)

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(12,716,500) (9.9%)


DIRECT COMPETITOR COMPARISON

X

AKS

MT

NUE

Industry

Market Cap:

5.61B

1.33B

41.68B

12.13B

615.49M

Employ ees:

43,000

6,500

282,000

20,400

2.95K

Qtrly Rev Growth (yoy):

41.70%

52.40%

23.30%

37.70%

17.10%

Revenue (ttm):

12.23B

4.56B

68.64B

12.19B

711.50M

Gross Margin (ttm):

-0.29%

10.75%

8.55%

4.03%

27.30%

-636.00M

305.70M

7.24B

712.19M

99.30M

-10.66%

1.92%

3.30%

1.13%

7.80%

-1.12B

1.10M

1.86B

-75.09M

N/A

-7.92

0.01

1.242

-0.238

0.64

P/E (ttm):

N/A

1207.00

22.22

N/A

16.83

PEG (5 yr expected):

0.63

1.57

N/A

1.83

1.44

P/S (ttm):

0.49

0.32

0.65

1.04

0.92

EBITDA (ttm): Oper Margins (ttm): Net Income (ttm): EPS (ttm):


Consolidated Investment Analysis for Citigroup Inc. Citigroup Inc. (NYSE: C) Company Description Citigroup Inc. (Citigroup) is a global diversified financial services holding company. The Company provides consumers, corporations, governments and institutions with a range of financial products and services. As of December 31, 2009, Citigroup had approximately 200 million customer accounts and did business in more than 140 countries. Citigroup operates through two primary business segments: Citicorp, consisting of its Regional Consumer Banking (RCB) businesses and Institutional Clients Group (ICG), and Citi Holdings, consisting of its Brokerage and Asset Management (BAM), Local Consumer Lending (LCL), and Special Asset Pool (SAP). In April 2010, Barclays PLC acquired Italian credit card business of Citibank International Bank plc. Share Statistics Symbol C Current Price 4.26 52wk Range 2.55- 5.43 Avg Vol (3m) 627,562,000

EPS Market Cap 52wk Change P/E (ttm)

-0.22 121.92B 43.43% N/A

Financial Summary On April 19, 2010, Citigroup Inc reported 1st quarter 2010 earnings of 0.15 per share. This result exceeded the breakeven consensus of the 16 analysts covering the companyand under-performed last year's 1st quarter results by 0.27. Citigroup Inc reported annual 2009 losses of -0.80 per share on January 19, 2010. C had 1st quarter 2010 revenues of 25.42bn. This bettered the 19.75bn consensus of the 8 analysts covering the company. This was 370.32% above the prior year's 1st quarter results. C had revenues for the full year 2009 of 80.29bn. This was 52.08% above the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 18 polled investment analysts. Against the Citigroup Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

5

2

9

1

1

0

4 weeks ago

5

2

9

1

1

0

2 months ago

4

2

9

1

2

0

3 months ago

4

2

8

1

2

1

Last year

0

2

6

1

1

1

The 16 analysts offering 12 month price targets for Citigroup Inc (C:NYQ) have a median target of 5.05, with a high estimate of 6.50 and a low estimate of 4.00. The median estimate represents a 14.51% increase from the last price of 4.41.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

9

22,260.80

24,272.00

19,007.00

--

Quarter Ending Sep-10

8

21,681.90

23,609.00

18,802.00

--

Year Ending Dec-10

13

89,212.80

95,529.00

71,642.00

91,133.40

Year Ending Dec-11

13

89,856.40

96,943.00

80,701.00

94,621.30

Quarter Ending Jun-10

16

0.05

0.10

-0.02

--

Quarter Ending Sep-10

15

0.05

0.10

-0.02

--

Year Ending Dec-10

18

0.28

0.45

0.04

0.23

Year Ending Dec-11

17

0.44

0.60

0.15

0.48

LT Growth Rate (%)

2

9.50

11.00

8.00

8.00

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans N/A

0

1,855

1

(1,855)

1

1.16B

N/A

0.0%

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

3,755,990,000 27.0%


DIRECT COMPETITOR COMPARISON

C

BAC

HBC

JPM

Industry

Market Cap:

121.92B

176.16B

N/A

168.63B

36.07B

Employ ees:

263,000

283,914

N/A

222,316

50.11K

Qtrly Rev Growth (yoy):

15.00%

-1.00%

N/A

25.80%

9.70%

Revenue (ttm):

44.11B

70.86B

N/A

72.65B

9.09B

Gross Margin (ttm):

N/A

N/A

N/A

N/A

0.00%

EBITDA (ttm):

N/A

N/A

N/A

N/A

N/A

-11.67%

10.94%

N/A

26.86%

30.10%

Net Income (ttm):

-3.74B

-2.19B

N/A

10.15B

N/A

EPS (ttm):

-0.222

-0.260

N/A

2.597

0.73

P/E (ttm):

N/A

N/A

N/A

16.35

18.67

PEG (5 yr expected):

N/A

4.12

N/A

1.93

1.35

P/S (ttm):

2.86

2.56

N/A

2.38

3.16

Oper Margins (ttm):


Report Disclaimer DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. We are not registered as a securities broker-dealer or an investment advisor either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them. Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stock broker before investing. This report is a service of Seo Freisin, Inc., a financial public relations firm that has been compensated by the companies profiled. All direct and third party compensation received has been disclosed on both, this newsletter, and on our website in accordance with section 17(b) of the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. Seo Freisin, Inc., and/or its affiliates will hold, buy, and sell securities in the companies profiled. When compensated in shares, all readers should be aware that it is our policy to liquidate all shares immediately. We reserve the right to buy or sell the shares of any the companies mentioned in any materials we produce at any time. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. ChartPoppers.com is a Web site wholly-owned by Seo Freisin, Inc. Seo Freisin, Inc., has not been compensated for any of the Companies mentioned in this report, we also do not own any shares in the companies discussed in this report. Information contained in our report will contain “forward looking statements” as defined under section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are


cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in this report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org


JNJ, AKS, GE, PFE, X, C